Leonard, H., Downs, J., Benke, T. A., Swanson, L., Olson, H., & Demarest, S. (2022). CDKL5 deficiency disorder: Clinical features, diagnosis, and management. The Lancet Neurology, 21(6), 563–576.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nevin, S. M., Wakefield, C. E., Schilstra, C. E., McGill, B. C., Bye, A., & Palmer, E. E. (2020). The information needs of parents of children with early-onset epilepsy: A systematic review. Epilepsy & Behavior, 112, 107382.

Article  Google Scholar 

Symonds, J. D., & McTague, A. (2020). Epilepsy and developmental disorders: Next generation sequencing in the clinic. European Journal of Paediatric Neurology, 24, 15–23.

Article  PubMed  Google Scholar 

EpiPM Consortium. (2015). A roadmap for precision medicine in the epilepsies. Lancet Neurology, 14(12), 1219–1228.

Article  Google Scholar 

Erickson, C. A., Kaufmann, W. E., Budimirovic, D. B., Lachiewicz, A., Haas-Givler, B., Miller, R. M., Weber, J. D., Abbeduto, L., Hessl, D., Hagerman, R. J., & Berry-Kravis, E. (2018). Best practices in Fragile X Syndrome treatment development. Brain Science, 8(12), 244.

Article  Google Scholar 

Leonard, H., Gold, W., Samaco, R., Sahin, M., Benke, T., & Downs, J. (2022). Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome. Orphanet Journal of Rare Diseases, 17(1), 108.

Article  PubMed  PubMed Central  Google Scholar 

de Vet, H. C. W., Terwee, C. B., Mokkink, L. B., & Knol, D. L. (2011). Measurement in medicine. Cambridge University Press.

Book  Google Scholar 

Mingorance, A., Jaksha, A., Smart, T., Sherriff, L., & Valentine, J. (2020). The Voice of the Patient Report: CDKL5 Deficiency Disorder (CDD): Lou Lou Foundation, International Foundation for CDKL5 Research,.

Baker, G. A., Hesdon, B., & Marson, A. G. (2000). Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards. Epilepsia, 41(11), 1357–1363.

Article  CAS  PubMed  Google Scholar 

Berg, A. T., Kaat, A. J., Zelko, F., & Wilkening, G. (2022). Rare diseases—Rare outcomes: Assessing communication abilities for the developmental and epileptic encephalopathies. Epilepsy & Behavior, 128, 108586.

Article  Google Scholar 

Saldaris, J., Leonard, H., Wong, K., Jacoby, P., Spence, M., Marsh, E., Benke, T. A., Demarest, S., & Downs, J. (In Press). Validating the Communication and Symbolic Behavior Scales—Developmental Profile Infant-Toddler Checklist (CSBS-DP ITC) beyond infancy in the CDKL5 Deficiency Disorder Journal of Autism and Developmental Disorders.

Berg, A. T., Kaat, A. J., & Gaebler-Spira, D. (2022). Measuring the inch stones for progress: Gross motor function in the developmental and epileptic encephalopathies. Epilepsy & Behavior, 137(Pt A), 108953.

Article  Google Scholar 

Leonard, H., Whitehouse, A., Jacoby, P., Benke, T., Demarest, S., Saldaris, J., Wong, K., Reddihough, D., Williams, K., & Downs, J. (2022). Quality of life beyond diagnosis in intellectual disability—Latent profiling. Research in Developmental Disabilities, 129, 104322.

Article  PubMed  PubMed Central  Google Scholar 

Berg, A. T., Palac, H., Wilkening, G., Zelko, F., & Schust Meyer, L. (2021). SCN2A-Developmental and Epileptic Encephalopathies: Challenges to trial-readiness for non-seizure outcomes. Epilepsia, 62(1), 258–268.

Article  CAS  PubMed  Google Scholar 

Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status: Ascertaining the minimal clinically important difference. Contemporary Clinical Trials, 10(4), 407–415.

Article  CAS  Google Scholar 

Juniper, E. F., Guyatt, G. H., Willan, A., & Griffith, L. E. (1994). Determining a minimal important change in a disease-specific quality of life questionnaire. Journal of Clinical Epidemiology, 47(1), 81–87.

Article  CAS  PubMed  Google Scholar 

Staunton, H., Willgoss, T., Nelsen, L., Burbridge, C., Sully, K., Rofail, D., & Arbuckle, R. (2019). An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments. J Patient Rep Outcomes, 3(1), 16.

Article  PubMed  PubMed Central  Google Scholar 

Hays, R. D., & Peipert, J. D. (2021). Between-group minimally important change versus individual treatment responders. Quality of Life Research, 30(10), 2765–2772.

Article  PubMed  PubMed Central  Google Scholar 

Food and Drug Administration. (2019). Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making: U.S. Food and Drug Administration.

Food and Drug Adminstration. (2023). Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments Into Endpoints for Regulatory Decision-Making, draft guidance: US Department of Health and Human Services.

Egan, S. M., Evans, L., Paltell, K. C., Kaiser, A., Nils, A., Anderson, E., Chapman, C., Coffman, K., Kaat, A. J., Nesbitt, G., Schust Meyer, L., & Berg, A. T. (2023). More than seizures: Expressive communication as a clinical trial Outcome for SCN2A-Developmental and Epileptic Encephalopathies. Epilepsy Currents. Annual meeting of the American Epilepsy Society, Nashville, TN, December, 2022.

Malterud, K., Siersma, V. D., & Guassora, A. D. (2016). Sample size in qualitative interview studies: Guided by information power. Qualitative Health Research, 26(13), 1753–1760.

Article  PubMed  Google Scholar 

Gonçalves, G. A. R., & Paiva, R. M. A. (2017). Gene therapy: Advances, challenges and perspectives. Einstein (Sao Paulo), 15(3), 369–375.

Article  PubMed  Google Scholar 

Hsieh, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288.

Article  PubMed  Google Scholar 

Guba, E. (1981). Criteria for assessing the trustworthiness of naturalistic inquiries. Educational Technology Research and Development, 29(2), 75.

Google Scholar 

Katz, N. P., Paillard, F. C., & Ekman, E. (2015). Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions. Journal of Orthopaedic Surgery and Research, 10, 24.

Article  PubMed  PubMed Central  Google Scholar 

Ferreira, M. L., & Herbert, R. D. (2008). What does “clinically important” really mean? The Australian Journal of Physiotherapy, 54(4), 229–230.

Article  PubMed  Google Scholar 

Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., Nordli, D. R., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y. H., & Zuberi, S. M. (2017). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 58(4), 512–521.

Article  PubMed  PubMed Central  Google Scholar 

Leonard, H., Benke, T., Diener, P. S., Feltner, D., Kaufmann, P., Lieberman, D. N., LoCicero, A., Macek, T. A., McGill, B. E., Miner, J. K., Muehring, L., Neul, J. L., O’Keefe, J. A., Ouyang, H., Percy, A., Tarquinio, D. C., & Downs, J. (2019). Establishing Clinical Trial Readiness of the Rett Syndrome Hand Function Measure (P1.6-034). Neurology, 92(15), 1.6-034.

Article  Google Scholar 

Palmer, E. E., Howell, K., & Scheffer, I. E. (2021). Natural history studies and clinical trial readiness for genetic developmental and epileptic encephalopathies. Neurotherapeutics, 18(3), 1432–1444.

Article  PubMed  PubMed Central  Google Scholar 

Saldaris, J., Leonard, H., Jacoby, P., Marsh, E. D., Benke, T. A., Demarest, S., & Downs, J. (2022). Initial validation and reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand). Journal of Child Neurology, 37(6), 541–547.

Article  PubMed  PubMed Central  Google Scholar 

Saldaris, J. M., Jacoby, P., Leonard, H., Benke, T. A., Demarest, S., Marsh, E. D., & Downs, J. (2023). Psychometric properties of QI-disability in CDKL5 deficiency disorder: Establishing readiness for clinical trials. Epilepsy & Behavior, 139, 109069.

Article  Google Scholar 

Felce, D., & Perry, J. (1995). Quality of life: Its definition and measurement. Research in Developmental Disabilities, 16(1), 51–74.

Article  CAS  PubMed  Google Scholar 

Downs, J., Jacoby, P., Leonard, H., Epstein, A., Murphy, N., Davis, E., Reddihough, D., Whitehouse, A., & Williams, K. (2019). Psychometric properties of the Quality of Life Inventory-Disability (QI-Disability) measure. Quality of Life Research, 28(3), 783–794.

Article  PubMed  Google Scholar 

Mori, Y., Downs, J., Wong, K., Heyworth, J., & Leonard, H. (2018). Comparing parental well-being and its determinants across three different genetic disorders causing intellectual disability. Journal of Autism and Developmental Disorders, 48(5), 1651–1665.

Article  PubMed  Google Scholar 

Reddihough, D., Leonard, H., Jacoby, P., Kim, R., Epstein, A., Murphy, N., Reid, S., Whitehouse, A., Williams, K., & Downs, J. (2021). Comorbidities and quality of life in children with intellectual disability. Child: Care, Health and Development, 47(5), 654–666.

Article  PubMed  Google Scholar 

Carter, B., McArthur, E., & Cunliffe, M. (2002). Dealing with uncertainty: Parental assessment of pain in their children with profound special needs. Journal of Advanced Nursing, 38(5), 449–457.

Article  PubMed  Google Scholar 

Weir, J. P. (2005). Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. Journal of Strength and Conditioning Research, 19(1), 231–240.

PubMed  Google Scholar 

Dolmage, T. E., Hill, K., Evans, R. A., & Goldstein, R. S. (2011). Has my patient responded? Interpreting clinical measurements such as the 6-minute-walk test. American Journal of Respiratory and Critical Care Medicine, 184(6), 642–646.

Article  PubMed  Google Scholar